Drug Delivery Devices Market Size, Growth & Demand

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Drug Delivery Devices Market Size Analysis

Global Drug Delivery Devices Market Introduction
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral Drug Delivery
  1. By Value
3. Injectable Drug Delivery
  1. By Value
4. Topical Drug Delivery
  1. By Value
5. Ocular Drug Delivery
  1. By Value
6. Pulmonary Drug Delivery
  1. By Value
7. Implantable Drug Delivery
  1. By Value
8. Transmucosal Drug Delivery
  1. By Value
9. Nasal Drug Delivery
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Infectious Diseases
  1. By Value
3. Cancer
  1. By Value
4. Cardiovascular Diseases
  1. By Value
5. Diabetes
  1. By Value
6. Respiratory Diseases
  1. By Value
7. Central Nervous System Disorders
  1. By Value
8. Autoimmune Diseases
  1. By Value
9. Other Applications
  1. By Value
By End-Use
1. Introduction
  1. End-Use By Value
2. Hospitals
  1. By Value
3. Ambulatory Surgery Centers
  1. By Value
4. Home Care Settings
  1. By Value
5. Diagnostic Centers
  1. By Value
6. Other Facilities of Use
  1. By Value

North America Market Analysis

Introduction
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral Drug Delivery
  1. By Value
3. Injectable Drug Delivery
  1. By Value
4. Topical Drug Delivery
  1. By Value
5. Ocular Drug Delivery
  1. By Value
6. Pulmonary Drug Delivery
  1. By Value
7. Implantable Drug Delivery
  1. By Value
8. Transmucosal Drug Delivery
  1. By Value
9. Nasal Drug Delivery
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Infectious Diseases
  1. By Value
3. Cancer
  1. By Value
4. Cardiovascular Diseases
  1. By Value
5. Diabetes
  1. By Value
6. Respiratory Diseases
  1. By Value
7. Central Nervous System Disorders
  1. By Value
8. Autoimmune Diseases
  1. By Value
9. Other Applications
  1. By Value
By End-Use
1. Introduction
  1. End-Use By Value
2. Hospitals
  1. By Value
3. Ambulatory Surgery Centers
  1. By Value
4. Home Care Settings
  1. By Value
5. Diagnostic Centers
  1. By Value
6. Other Facilities of Use
  1. By Value
U.S.
1. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral Drug Delivery
    1. By Value
  3. Injectable Drug Delivery
    1. By Value
  4. Topical Drug Delivery
    1. By Value
  5. Ocular Drug Delivery
    1. By Value
  6. Pulmonary Drug Delivery
    1. By Value
  7. Implantable Drug Delivery
    1. By Value
  8. Transmucosal Drug Delivery
    1. By Value
  9. Nasal Drug Delivery
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Infectious Diseases
    1. By Value
  3. Cancer
    1. By Value
  4. Cardiovascular Diseases
    1. By Value
  5. Diabetes
    1. By Value
  6. Respiratory Diseases
    1. By Value
  7. Central Nervous System Disorders
    1. By Value
  8. Autoimmune Diseases
    1. By Value
  9. Other Applications
    1. By Value
3. By End-Use
  1. Introduction
    1. End-Use By Value
  2. Hospitals
    1. By Value
  3. Ambulatory Surgery Centers
    1. By Value
  4. Home Care Settings
    1. By Value
  5. Diagnostic Centers
    1. By Value
  6. Other Facilities of Use
    1. By Value
Canada

Europe Market Analysis

Introduction
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral Drug Delivery
  1. By Value
3. Injectable Drug Delivery
  1. By Value
4. Topical Drug Delivery
  1. By Value
5. Ocular Drug Delivery
  1. By Value
6. Pulmonary Drug Delivery
  1. By Value
7. Implantable Drug Delivery
  1. By Value
8. Transmucosal Drug Delivery
  1. By Value
9. Nasal Drug Delivery
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Infectious Diseases
  1. By Value
3. Cancer
  1. By Value
4. Cardiovascular Diseases
  1. By Value
5. Diabetes
  1. By Value
6. Respiratory Diseases
  1. By Value
7. Central Nervous System Disorders
  1. By Value
8. Autoimmune Diseases
  1. By Value
9. Other Applications
  1. By Value
By End-Use
1. Introduction
  1. End-Use By Value
2. Hospitals
  1. By Value
3. Ambulatory Surgery Centers
  1. By Value
4. Home Care Settings
  1. By Value
5. Diagnostic Centers
  1. By Value
6. Other Facilities of Use
  1. By Value
U.K.
1. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral Drug Delivery
    1. By Value
  3. Injectable Drug Delivery
    1. By Value
  4. Topical Drug Delivery
    1. By Value
  5. Ocular Drug Delivery
    1. By Value
  6. Pulmonary Drug Delivery
    1. By Value
  7. Implantable Drug Delivery
    1. By Value
  8. Transmucosal Drug Delivery
    1. By Value
  9. Nasal Drug Delivery
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Infectious Diseases
    1. By Value
  3. Cancer
    1. By Value
  4. Cardiovascular Diseases
    1. By Value
  5. Diabetes
    1. By Value
  6. Respiratory Diseases
    1. By Value
  7. Central Nervous System Disorders
    1. By Value
  8. Autoimmune Diseases
    1. By Value
  9. Other Applications
    1. By Value
3. By End-Use
  1. Introduction
    1. End-Use By Value
  2. Hospitals
    1. By Value
  3. Ambulatory Surgery Centers
    1. By Value
  4. Home Care Settings
    1. By Value
  5. Diagnostic Centers
    1. By Value
  6. Other Facilities of Use
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral Drug Delivery
  1. By Value
3. Injectable Drug Delivery
  1. By Value
4. Topical Drug Delivery
  1. By Value
5. Ocular Drug Delivery
  1. By Value
6. Pulmonary Drug Delivery
  1. By Value
7. Implantable Drug Delivery
  1. By Value
8. Transmucosal Drug Delivery
  1. By Value
9. Nasal Drug Delivery
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Infectious Diseases
  1. By Value
3. Cancer
  1. By Value
4. Cardiovascular Diseases
  1. By Value
5. Diabetes
  1. By Value
6. Respiratory Diseases
  1. By Value
7. Central Nervous System Disorders
  1. By Value
8. Autoimmune Diseases
  1. By Value
9. Other Applications
  1. By Value
By End-Use
1. Introduction
  1. End-Use By Value
2. Hospitals
  1. By Value
3. Ambulatory Surgery Centers
  1. By Value
4. Home Care Settings
  1. By Value
5. Diagnostic Centers
  1. By Value
6. Other Facilities of Use
  1. By Value
China
1. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral Drug Delivery
    1. By Value
  3. Injectable Drug Delivery
    1. By Value
  4. Topical Drug Delivery
    1. By Value
  5. Ocular Drug Delivery
    1. By Value
  6. Pulmonary Drug Delivery
    1. By Value
  7. Implantable Drug Delivery
    1. By Value
  8. Transmucosal Drug Delivery
    1. By Value
  9. Nasal Drug Delivery
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Infectious Diseases
    1. By Value
  3. Cancer
    1. By Value
  4. Cardiovascular Diseases
    1. By Value
  5. Diabetes
    1. By Value
  6. Respiratory Diseases
    1. By Value
  7. Central Nervous System Disorders
    1. By Value
  8. Autoimmune Diseases
    1. By Value
  9. Other Applications
    1. By Value
3. By End-Use
  1. Introduction
    1. End-Use By Value
  2. Hospitals
    1. By Value
  3. Ambulatory Surgery Centers
    1. By Value
  4. Home Care Settings
    1. By Value
  5. Diagnostic Centers
    1. By Value
  6. Other Facilities of Use
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral Drug Delivery
  1. By Value
3. Injectable Drug Delivery
  1. By Value
4. Topical Drug Delivery
  1. By Value
5. Ocular Drug Delivery
  1. By Value
6. Pulmonary Drug Delivery
  1. By Value
7. Implantable Drug Delivery
  1. By Value
8. Transmucosal Drug Delivery
  1. By Value
9. Nasal Drug Delivery
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Infectious Diseases
  1. By Value
3. Cancer
  1. By Value
4. Cardiovascular Diseases
  1. By Value
5. Diabetes
  1. By Value
6. Respiratory Diseases
  1. By Value
7. Central Nervous System Disorders
  1. By Value
8. Autoimmune Diseases
  1. By Value
9. Other Applications
  1. By Value
By End-Use
1. Introduction
  1. End-Use By Value
2. Hospitals
  1. By Value
3. Ambulatory Surgery Centers
  1. By Value
4. Home Care Settings
  1. By Value
5. Diagnostic Centers
  1. By Value
6. Other Facilities of Use
  1. By Value
UAE
1. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral Drug Delivery
    1. By Value
  3. Injectable Drug Delivery
    1. By Value
  4. Topical Drug Delivery
    1. By Value
  5. Ocular Drug Delivery
    1. By Value
  6. Pulmonary Drug Delivery
    1. By Value
  7. Implantable Drug Delivery
    1. By Value
  8. Transmucosal Drug Delivery
    1. By Value
  9. Nasal Drug Delivery
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Infectious Diseases
    1. By Value
  3. Cancer
    1. By Value
  4. Cardiovascular Diseases
    1. By Value
  5. Diabetes
    1. By Value
  6. Respiratory Diseases
    1. By Value
  7. Central Nervous System Disorders
    1. By Value
  8. Autoimmune Diseases
    1. By Value
  9. Other Applications
    1. By Value
3. By End-Use
  1. Introduction
    1. End-Use By Value
  2. Hospitals
    1. By Value
  3. Ambulatory Surgery Centers
    1. By Value
  4. Home Care Settings
    1. By Value
  5. Diagnostic Centers
    1. By Value
  6. Other Facilities of Use
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral Drug Delivery
  1. By Value
3. Injectable Drug Delivery
  1. By Value
4. Topical Drug Delivery
  1. By Value
5. Ocular Drug Delivery
  1. By Value
6. Pulmonary Drug Delivery
  1. By Value
7. Implantable Drug Delivery
  1. By Value
8. Transmucosal Drug Delivery
  1. By Value
9. Nasal Drug Delivery
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Infectious Diseases
  1. By Value
3. Cancer
  1. By Value
4. Cardiovascular Diseases
  1. By Value
5. Diabetes
  1. By Value
6. Respiratory Diseases
  1. By Value
7. Central Nervous System Disorders
  1. By Value
8. Autoimmune Diseases
  1. By Value
9. Other Applications
  1. By Value
By End-Use
1. Introduction
  1. End-Use By Value
2. Hospitals
  1. By Value
3. Ambulatory Surgery Centers
  1. By Value
4. Home Care Settings
  1. By Value
5. Diagnostic Centers
  1. By Value
6. Other Facilities of Use
  1. By Value
Brazil
1. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral Drug Delivery
    1. By Value
  3. Injectable Drug Delivery
    1. By Value
  4. Topical Drug Delivery
    1. By Value
  5. Ocular Drug Delivery
    1. By Value
  6. Pulmonary Drug Delivery
    1. By Value
  7. Implantable Drug Delivery
    1. By Value
  8. Transmucosal Drug Delivery
    1. By Value
  9. Nasal Drug Delivery
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Infectious Diseases
    1. By Value
  3. Cancer
    1. By Value
  4. Cardiovascular Diseases
    1. By Value
  5. Diabetes
    1. By Value
  6. Respiratory Diseases
    1. By Value
  7. Central Nervous System Disorders
    1. By Value
  8. Autoimmune Diseases
    1. By Value
  9. Other Applications
    1. By Value
3. By End-Use
  1. Introduction
    1. End-Use By Value
  2. Hospitals
    1. By Value
  3. Ambulatory Surgery Centers
    1. By Value
  4. Home Care Settings
    1. By Value
  5. Diagnostic Centers
    1. By Value
  6. Other Facilities of Use
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Drug Delivery Devices Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Johnson & Johnson (US),
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Novartis International AG (Switzerland),
F. Hoffmann-La Roche AG (Switzerland),
Pfizer Inc. (US),
Bayer AG (Germany),
Antares Pharma, Inc. (US),
Becton, Dickinson and Company (US),
GlaxoSmithKline plc (UK),
3M (US),
Merck & Co., Inc. (US),
Sanofi (France),
Amgen, Inc. (US),
AbbVie Inc. (US),
Genmab A/S (Denmark),
Gilead Sciences, Inc. (US),
Boehringer Ingelheim (Germany),
AstraZeneca plc. (UK),
Eli Lilly and Company (UK),
Teva Pharmaceuticals Industries Ltd. (Israel),
Bristol-Myers Squibb (US),
Gerresheimer AG (Germany),
Boston Scientific Corporation (US),
Nimbus Therapeutics (US),
Kite Pharma (US),
IDEAYA Biosciences, Inc. (US).

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment